Cargando…

QTc and psychopharmacs: are there any differences between monotherapy and polytherapy

BACKGROUND: Some psychotropic drugs are connected with prolongation of QT interval, increased risk of cardiac arrhythmias and greater incidence of sudden death, especially when used in combination. Concomitant use of antipsychotics and antidepressants is not rare in our clinical practice. The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumić, Jadranka Čulav, Barić, Vesna, Bilić, Petar, Herceg, Miroslav, Sisek-Šprem, Mirna, Jukić, Vlado
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871590/
https://www.ncbi.nlm.nih.gov/pubmed/17477877
http://dx.doi.org/10.1186/1744-859X-6-13
_version_ 1782133440003440640
author Sumić, Jadranka Čulav
Barić, Vesna
Bilić, Petar
Herceg, Miroslav
Sisek-Šprem, Mirna
Jukić, Vlado
author_facet Sumić, Jadranka Čulav
Barić, Vesna
Bilić, Petar
Herceg, Miroslav
Sisek-Šprem, Mirna
Jukić, Vlado
author_sort Sumić, Jadranka Čulav
collection PubMed
description BACKGROUND: Some psychotropic drugs are connected with prolongation of QT interval, increased risk of cardiac arrhythmias and greater incidence of sudden death, especially when used in combination. Concomitant use of antipsychotics and antidepressants is not rare in our clinical practice. The study compares the length of QT interval in patients on monotherapy with an antipsychotic or an antidepressant and patients taking polytherapy (an antipsychotic agent combined with an antidepressant). METHODS: Sixty-one hospitalized women who met the ICD-10 criteria for schizophrenia, schizoaffective psychosis, delusional disorder and mood disorder were included in the study. The monotherapy group was consisted of thirty-two women treated with an antipsychotic or an antidepressant while the polytherapy group was composed of twenty-nine women treated with an antipsychotic agent plus an antidepressant. Two electrocardiograms (ECGs) were obtained for each patient: the first was carried out before the treatment and the second after two weeks of treatment. Statistical analysis was carried out by SPSS program and included unpaired and paired t test and Fisher's exact test. RESULTS: Mean baseline QTc values did not differ between the groups (439 ± 22 ms was the same value found in the both groups; unpaired t test, p > 0.5). Mean QTc intervals after two weeks of treatment were also similar (439 ± 24 ms in the monotherapy group and 440 ± 20 ms in the polytherapy group; unpaired t test, p > 0.5). Fisher's exact test did not reveal significant difference in the number of patients with borderline (451–470 ms) or prolonged (> 470 ms) QTc between groups, neither before treatment nor after two weeks of treatment. Twenty two women of the total of sixty one patients (36%) had QTc > 450 ms before applying therapy. CONCLUSION: We did not find significant QT prolongation in our patients after two weeks of treatment with antipsychotics and/or antidepressants. The QTc interval length did not differ significantly in the monotherapy and the polytherapy group. More than one third of included women exceeded the threshold value of borderline QTc interval (450 ms) before starting treatment. This finding calls for caution when prescribing drugs to female psychiatric patients, especially if they have other health problems.
format Text
id pubmed-1871590
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18715902007-05-17 QTc and psychopharmacs: are there any differences between monotherapy and polytherapy Sumić, Jadranka Čulav Barić, Vesna Bilić, Petar Herceg, Miroslav Sisek-Šprem, Mirna Jukić, Vlado Ann Gen Psychiatry Primary Research BACKGROUND: Some psychotropic drugs are connected with prolongation of QT interval, increased risk of cardiac arrhythmias and greater incidence of sudden death, especially when used in combination. Concomitant use of antipsychotics and antidepressants is not rare in our clinical practice. The study compares the length of QT interval in patients on monotherapy with an antipsychotic or an antidepressant and patients taking polytherapy (an antipsychotic agent combined with an antidepressant). METHODS: Sixty-one hospitalized women who met the ICD-10 criteria for schizophrenia, schizoaffective psychosis, delusional disorder and mood disorder were included in the study. The monotherapy group was consisted of thirty-two women treated with an antipsychotic or an antidepressant while the polytherapy group was composed of twenty-nine women treated with an antipsychotic agent plus an antidepressant. Two electrocardiograms (ECGs) were obtained for each patient: the first was carried out before the treatment and the second after two weeks of treatment. Statistical analysis was carried out by SPSS program and included unpaired and paired t test and Fisher's exact test. RESULTS: Mean baseline QTc values did not differ between the groups (439 ± 22 ms was the same value found in the both groups; unpaired t test, p > 0.5). Mean QTc intervals after two weeks of treatment were also similar (439 ± 24 ms in the monotherapy group and 440 ± 20 ms in the polytherapy group; unpaired t test, p > 0.5). Fisher's exact test did not reveal significant difference in the number of patients with borderline (451–470 ms) or prolonged (> 470 ms) QTc between groups, neither before treatment nor after two weeks of treatment. Twenty two women of the total of sixty one patients (36%) had QTc > 450 ms before applying therapy. CONCLUSION: We did not find significant QT prolongation in our patients after two weeks of treatment with antipsychotics and/or antidepressants. The QTc interval length did not differ significantly in the monotherapy and the polytherapy group. More than one third of included women exceeded the threshold value of borderline QTc interval (450 ms) before starting treatment. This finding calls for caution when prescribing drugs to female psychiatric patients, especially if they have other health problems. BioMed Central 2007-05-03 /pmc/articles/PMC1871590/ /pubmed/17477877 http://dx.doi.org/10.1186/1744-859X-6-13 Text en Copyright © 2007 Sumić et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Primary Research
Sumić, Jadranka Čulav
Barić, Vesna
Bilić, Petar
Herceg, Miroslav
Sisek-Šprem, Mirna
Jukić, Vlado
QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title_full QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title_fullStr QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title_full_unstemmed QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title_short QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
title_sort qtc and psychopharmacs: are there any differences between monotherapy and polytherapy
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871590/
https://www.ncbi.nlm.nih.gov/pubmed/17477877
http://dx.doi.org/10.1186/1744-859X-6-13
work_keys_str_mv AT sumicjadrankaculav qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy
AT baricvesna qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy
AT bilicpetar qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy
AT hercegmiroslav qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy
AT sisekspremmirna qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy
AT jukicvlado qtcandpsychopharmacsarethereanydifferencesbetweenmonotherapyandpolytherapy